With the new program, patients using Amazon Pharmacy will no longer have to search for and manually enter coupons from the three largest in...

The lack of regulatory clarity is imperiling India’s online pharmacy sector. While the digital business has grown rapidly in the past few y...

Platforms to submit formal presentation via industry associations before potential regulation.

The programme, named RxPass, includes more than 50 medications addressing over 80 chronic conditions such as high blood pressure, anxiety, ...

India’s online pharmacy sector, dominated by Pharmeasy, 1mg and Netmeds, was among the biggest beneficiaries of the pandemic-induced lockdo...

A potential investment in Apollo could provide Amazon access to 3,700 outlets whereby it can pick products directly from retail stores and ...

Any doubt that e-pharmacies would not be sustainable is now gone, industry analysts and executives told ET, because sales through online ph...

The company opened an online pharmacy Tuesday, giving Amazon shoppers the chance to buy their medication and order refills on their phones ...

If the transaction goes through, it could significantly alter the face of India’s fledgling e-pharmacy sector, with two of the country’s bi...

The All India Organisation of Chemists and Druggists (AIOCD), which claims to represent 8.5 lakh chemists, on August 14 wrote to Bezos and ...

India's $20-billion pharmaceutical industry is set for a shakeup as giants Reliance Retail and Amazon chart plans to enter the e-pharmacy s...

Both Amazon and Flipkart's interest in medicine delivery comes at a time when the industry is seeing consolidation with Reliance Industries...

“E-pharmacies are illegal and not recognised by the laws under the Drug & Cosmetics Act. The rules also say sale of certain drugs need to b...

The move comes amid increasing competition in India with rivals Walmart-owned Flipkart, billionaire Mukesh Ambani's upstart online grocery ...

Flipkart, Amazon, BigBasket and Swiggy are all in exploratory talks to acquire, partner or invest in online pharma players.

The official further added that pressure on domestic generics should not increase any further than it already has after increased channel c...

The sub-committee, which is expected to come up with a set of norms shortly, was formed by Drugs Controller General of India to assess feas...